News: Suppliers
1 October 2025
Riber’s first-half 2025 revenue and earnings impacted by deliveries being concentrated into second-half
Molecular beam epitaxy (MBE) system maker Riber S.A. of Bezons, France has confirmed a 22% drop in revenue from €13.7m in first-half 2024 to €10.7m for first-half 2025, reflecting a delivery schedule that is concentrated into second-half 2025. The firm says that, in a complex international environment, it recorded solid commercial activity, despite particularly pronounced seasonality.
MBE Systems revenue fell by 17% from €9.4m to €7.8m, comprising the delivery of three machines (including two production systems) compared with three production systems in the same period last year.
Services & Accessories revenues fell by 31% from €4.3m to €3m.
Gross margin rises, despite net loss
Given the traditional seasonality of sales, first-half results cannot be extrapolated to the full year, notes Riber. This trend is reinforced in 2025, with only around one quarter of revenue generated in the first half, which nevertheless bears nearly half of fixed costs.
Despite the drop in revenue, gross margin has risen from 34.8% in first-half 2024 to 36.2% in first-half 2025. Including net financial expenses of €0.1m, net loss was €0.8m, compared with a profit of €0.2m in first-half 2024.
During first-half 2025, net cash fell from €8.6m to €2.5m, reflecting the impact of delivery seasonality on working capital requirements, the distribution to shareholders from the issue premium paid out in June, and sustained levels of investment. Shareholders’ equity fell from €23.6m to €21.3m, primarily due to the half-year earnings and the distribution to shareholders from the issue premium.
Order development in first-half 2025
Riber says that it continues to strengthen the appeal of its technological offering with the rollout of its silicon photonics roadmap and the signing of the first two sales of its (Riber Oxide on SIlicon Epitaxy) platform, a key step towards industrialization of this innovative equipment. This momentum is reflected in the sustained level of order intake, with a total of nine systems ordered over the first nine months of 2025, both for research and for industrial production, particularly in the fields of datacom and quantum technologies. However, Services & Accessories activities are affected by economic uncertainties weighing particularly on the research sector, notes Riber.
At end-June 2025, the order book was €27.7m, down 23% on €36m at end-June 2024. MBE System orders fell by 25% from €30.2m to €22.5m (comprising nine machines, including six for production), due to the denial of two export licenses (representing €4m in lost orders) and longer approval time-lines for licenses. Orders for Services & Accessories fell by 11% from €5.8m to €5.2m.
However, this does not include the orders announced in August and September (two MBE 6000 production systems, one ROSIE machine, and one Compact 21 research system), worth a total of about €14m.
Outlook
In a context marked by the rollout of major investment programs in artificial intelligence (AI) and quantum technologies, Riber expects new orders in fourth-quarter 2025.
The ramp-up of ROSIE is being confirmed with the sale of the first two units, validating the growing interest from laboratories and industrial players for solutions compatible with silicon production lines, says Riber.
Given the visibility of its order book deliverable in 2025 and the opportunities for its equipment and services, Riber confirms its target of revenues above €40m for full-year 2025.
Riber’s first-half revenue falls 22% year-on-year to €10.7m
Riber partners with Denmark’s NQCP, initiating phase II of ROSIE
Riber’s annual revenue grows 4.8% to €41.2m
Riber reports positive earnings in first-half 2024, as revenue grows by 13%